Asymmetric Dimethylarginine as a Surrogate Marker of Endothelial Dysfunction and Cardiovascular Risk in Patients with Systemic Rheumatic Diseases

By Dimitroulas Theodoros   Sandoo Aamer   Kitas George D.  

International Journal of Molecular Sciences, Vol. 13, Iss. 10, 2012-09 ,pp. : 12315-12335

MDPI

Access to resources Recommend Favorite

Evaluating of Physiological Chemical Levels in Blood to Assess the Risk of Morbidity and Mortality of Ischemic Cardiovascular Disease

By Teng Junyan   Wei Yanping   Su Fengming   Guo Zhiping   Zhong Jing-Quan  

International Journal of Environmental Research and Public Health, Vol. 12, Iss. 9, 2015-09 ,pp. : 11549-11559

MDPI

Access to resources Recommend Favorite

Asymmetric Dimethylarginine Plasma Levels and Endothelial Function in Newly Diagnosed Type 2 Diabetic Patients

By Sciacqua Angela   Grillo Nadia   Quero Michele   Sesti Giorgio   Perticone Francesco  

International Journal of Molecular Sciences, Vol. 13, Iss. 11, 2012-10 ,pp. : 13804-13815

MDPI

Access to resources Recommend Favorite

Biological Functional Relevance of Asymmetric Dimethylarginine (ADMA) in Cardiovascular Disease

By Franceschelli Sara   Ferrone Alessio   Pesce Mirko   Riccioni Graziano   Speranza Lorenza  

International Journal of Molecular Sciences, Vol. 14, Iss. 12, 2013-12 ,pp. : 24412-24421

MDPI

Access to resources Recommend Favorite

Asymmetric Dimethylarginine versus Proton Pump Inhibitors Usage in Patients with Stable Coronary Artery Disease: A Cross-Sectional Study

By Kruszelnicka Olga   Świerszcz Jolanta   Bednarek Jacek   Chyrchel Bernadeta   Surdacki Andrzej   Nessler Jadwiga  

International Journal of Molecular Sciences, Vol. 17, Iss. 4, 2016-04 ,pp. : 454-454

MDPI

Access to resources Recommend Favorite